Early Real-World Experience of Tofacitinib for Psoriatic Arthritis: Data from a United States Healthcare Claims Database

INTRODUCTION: This study characterized real-world demographic and baseline clinical characteristics, as well as treatment persistence and adherence, in patients with psoriatic arthritis (PsA) who had newly initiated tofacitinib treatment. METHODS: This retrospective cohort study included patients ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Mease, Philip J., Young, Pamela, Gruben, David, Fallon, Lara, Germino, Rebecca, Kavanaugh, Arthur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123050/
https://www.ncbi.nlm.nih.gov/pubmed/35482248
http://dx.doi.org/10.1007/s12325-022-02084-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123050/
https://www.ncbi.nlm.nih.gov/pubmed/35482248
http://dx.doi.org/10.1007/s12325-022-02084-7

Ejemplares similares